Abstract: Antibodies against coronavirus receptor binding domain (SARS-CoV-2) are provided. The antibodies have neutralizing activity against coronaviruses and their activity. The anti-coronavirus receptor binding domain antibodies may be used in therapeutic treatment in patients with coronavirus infections and/or conditions associated with coronavirus infection.
Type:
Application
Filed:
October 8, 2021
Publication date:
November 30, 2023
Inventors:
Kaitlyn Noelle SADTLER, Matthew James MEMOLI